Found: 27
Select item for more details and to access through your institution.
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193m Pt and 195m Pt Radionuclides in Auger Electron Therapy.
- Published in:
- Molecules, 2021, v. 26, n. 7, p. 2051, doi. 10.3390/molecules26072051
- By:
- Publication type:
- Article
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Cancer epidemiology in Central, South, and Eastern European countries.
- Published in:
- Croatian Medical Journal, 2011, v. 52, n. 4, p. 478, doi. 10.3325/cmj.2011.52.478
- By:
- Publication type:
- Article
A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 129, doi. 10.1159/000318043
- By:
- Publication type:
- Article
RAK PIERSI - WYBRANE ASPEKTY LECZENIA SYSTEMOWEGO.
- Published in:
- Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 2014, p. S1
- By:
- Publication type:
- Article
TOPOISOMERASE 2α STATUS IN INVASIVE BREAST CARCINOMA - COMPARISON OF ITS CLINICAL VALUE ACCORDING TO IMMUNOHISTOCHEMICAL AND FLUORESCENCE IN SITU HYBRIDIZATION METHODS OF EVALUATION.
- Published in:
- Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 2014, v. 65, n. 4, p. 283, doi. 10.5114/PJP.2014.48189
- By:
- Publication type:
- Article
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2355, doi. 10.1002/1878-0261.13141
- By:
- Publication type:
- Article
Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 812, doi. 10.1634/theoncologist.2013-0091
- By:
- Publication type:
- Article
Prognostic Significance of TOP2A Gene Dosage in HER-2-Negative Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 10, p. 1246, doi. 10.1634/theoncologist.2012-0023
- By:
- Publication type:
- Article
Delays in diagnosis and treatment of breast cancer: a multinational analysis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Delays in diagnosis and treatment of breast cancer: a multinational analysis.
- Published in:
- European Journal of Public Health, 2014, v. 24, n. 5, p. 761, doi. 10.1093/eurpub/ckt131
- By:
- Publication type:
- Article
Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 7, p. 1027, doi. 10.1080/02841860701316099
- By:
- Publication type:
- Article
Noncardiac surgery in Eisenmenger syndrome.
- Published in:
- Polish Archives of Internal Medicine, 2024, v. 134, n. 2, p. 1, doi. 10.20452/pamw.16652
- By:
- Publication type:
- Article
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer.
- Published in:
- Oncologist, 2006, v. 11, p. 4, doi. 10.1634/theoncologist.11-90001-4
- By:
- Publication type:
- Article
Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer.
- Published in:
- Oncologist, 2006, v. 11, p. 4, doi. 10.1634/theoncologist.11-90001-4
- By:
- Publication type:
- Article
Pertuzumab for First-Line Treatment of HER2+ Advanced Breast Cancer: Where Does It Fit?
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 2, p. 25, doi. 10.13032/tjop.2052-5931.100082
- By:
- Publication type:
- Article
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients.
- Published in:
- Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0388-4
- By:
- Publication type:
- Article
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 112, n. 3, p. 533, doi. 10.1007/s10549-007-9885-0
- By:
- Publication type:
- Article
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 755, doi. 10.1007/s00280-009-1081-y
- By:
- Publication type:
- Article
Current perspective on smoking epidemics in Poland - statement the Polish Society of Public Health.
- Published in:
- Annals of Agricultural & Environmental Medicine, 2022, v. 29, n. 3, p. 348, doi. 10.26444/aaem/151458
- By:
- Publication type:
- Article
Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 10, p. 1481, doi. 10.1515/CCLM.2010.278
- By:
- Publication type:
- Article
Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2006, v. 44, n. 9, p. 1092, doi. 10.1515/CCLM.2006.192
- By:
- Publication type:
- Article
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article